Sunday, November 19, 2017 10:01:52 AM
Entered very small at 59.
What is problematic is the lack of deals and mergers being done. They look to have 2 superstar blockbusters and the stock may very well be 80 to 100 if a buyout were to occur.
That is less likely though as they are hiring their own sales force. Not only does that present the problem of salesman having a one trick pony product for now, but they have zero experience running a sales team. Even hiring experienced people from big pharma is not encouraging as they are use to having a portfolio of drugs, established relationships and a huge marketing budget. There is a possibility of the product having a label as well.
This is not a Gilead situation where a drug takes over a market immediately. Most small biotech’s lose money for at least 3 years, and lose a lot of money. Aeri could bled 100’s if millions of dollars before it reaches us profitable, and the over under on pivoting to profits is 3.5 years.
The upside is that Aeri could be a billion dollar drug, or more. We bought Aeri for turnaround and buyout just like rite aid, Salix, Receptos, Sarepta BMY.
Aeri seemed a perfect fit for AGN, but it is not looking like that now. Tax reform doesn’t benefit AGN. Maybe they will get bought out but not optimistic at this point.
Recent AERI News
- Aquila European Renewables PLC Dividend Declaration • RNS Regulatory News • 05/03/2024 06:00:10 AM
- Aquila European Renewables PLC Net Asset Value & Factsheet • RNS Regulatory News • 05/03/2024 06:00:10 AM
- LSL starts 2024 "strongly"; Focusrite maintains payout • Alliance News • 04/25/2024 11:19:17 AM
- Aquila European Renewables PLC Final Results • RNS Regulatory News • 04/25/2024 06:00:12 AM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 04/23/2024 04:22:37 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 04/22/2024 04:32:34 PM
- Aquila European Renewables PLC Notice of Results • RNS Regulatory News • 04/12/2024 06:00:11 AM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 04/11/2024 04:40:49 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 03/28/2024 06:26:07 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 03/28/2024 05:13:34 PM
- Aquila European instructed to adopt measures to protect reindeer • Alliance News • 03/22/2024 12:49:05 PM
- Aquila European Renewables PLC The Rock Mitigation Measures update • RNS Regulatory News • 03/22/2024 12:07:02 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 03/07/2024 04:36:17 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 02/27/2024 02:42:49 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 02/27/2024 09:59:01 AM
- Begbies trading in line; Probiotix inks partnership • Alliance News • 02/26/2024 08:17:54 PM
- Octopus Renewables Infra Trust PLC Response to announcement by AERI / AERS • RNS Regulatory News • 02/26/2024 03:48:48 PM
- Aquila European Renewables begins combination process • Alliance News • 02/26/2024 10:19:21 AM
- Aquila European Renewables PLC Company Update • RNS Regulatory News • 02/26/2024 07:00:03 AM
- Aquila European Renewables PLC Exchange rate for the 4th Interim Dividend • RNS Regulatory News • 02/22/2024 12:50:30 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 02/20/2024 02:38:53 PM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 02/12/2024 07:00:08 AM
- Aquila European Renewables PLC Dividend Declaration • RNS Regulatory News • 02/06/2024 07:00:08 AM
- Aquila European Renewables PLC Net Asset Value and Factsheet • RNS Regulatory News • 02/06/2024 07:00:08 AM
- Aquila European Renewables PLC Holding(s) in Company • RNS Regulatory News • 02/06/2024 07:00:08 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM